TÜBINGEN, Germany – December 28, 2017
CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, announced today that Ingmar Hoerr, Ph.D., co-founder and CEO of CureVac, will present at the J.P. Morgan 35th Annual Healthcare Conference 2017 to be held January 9-12, 2017, at the Westin St. Francis Hotel in San Francisco, CA.
Details of CureVac’s presentation are as follows:
| Event: | J.P. Morgan 35th Annual Healthcare Conference 2017 |
| Date: | Wednesday, January 11, 2017 |
| Time: | 2:00 p.m. (Pacific Time) |
| Location: | Westin St. Francis Hotel, San Francisco, CA |
Media Contacts
Andrew Mielach
Vice President
Tiberend Strategic Advisors, New York
T +1 212 375 2694
Email